Skip to main content
Home
Medic Debate
- The Antidote to Medical Misinformation and Propaganda!

Languages

Search form

Main menu

  • Home
  • Search
  • Category Search
  • Log In
  • Peoples Court
  • Recent posts
  • Treatment Protocols

You are here

Home

Gefitinib

Title Average Ratingsort ascending
Lessons learned in the development of targeted therapy for malignant gliomas 50.00%
Hepatocyte growth factor as inducer of gefitinib resistance in non-small cell lung cancer harboring EGFR activating mutations. 40.00%